Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06703346 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06703346 · ClinicalTrials.gov record · last posted 2026-08-13

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Name: Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma — clinical trial record (NCT06703346)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhasePhase 2

SponsorUSWM CT, LLC

Started2019-12-31

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors. This trial is a sub study of the Master study NCT03967223.

Protocol amendment history 1 change detected by DataLookout

2026-08-14

Trial completed

Trial Details

NCT Number	NCT06703346
Lead Sponsor	USWM CT, LLC
Conditions	Neoplasms
Enrollment	82 participants
Start Date	2019-12-31
Primary Completion	2024-03-01 (estimated)
Study Completion	2026-07-24 (estimated)
Updated on ClinicalTrials.gov	2026-08-13